FDA Inspection 1202870 — Sharad A. Ghamande, M.D.
The FDA completed an inspection of Sharad A. Ghamande, M.D. on April 5, 2023 in Augusta, GA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- April 5, 2023
- Fiscal Year
- 2023
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Augusta, GA (United States)
Additional Details
Clinical Investigator (CI)